Magdalena Bieniasz to Tumor Burden
This is a "connection" page, showing publications Magdalena Bieniasz has written about Tumor Burden.
Connection Strength
0.123
-
Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts. Clin Cancer Res. 2015 Dec 15; 21(24):5588-600.
Score: 0.123